Augtyro (repotrectinib) - BMS
Augtyro: Newly added patent in Orange Book (Orange Book) - Jul 7, 2025 - Expiry on Jul 20, 2036 
Patent • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Thoracic Cancer
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
 
Jul 7, 2025
 
 
c87f7496-7679-45b7-8996-5abfe6c0964c.png